CYTOO logo

CYTOO

34 employees · est. 2008 · Grenoble, France

VS
FluoSphera logo

FluoSphera

The only company with a suite of systemic and high-throughput in vitro drug discovery solutions

6 employees · est. 2021 · Geneva, Switzerland

CYTOO is the older company (2008 vs 2021); CYTOO is the larger of the two.

Side-by-Side Comparison

CYTOO FluoSphera
Founded
2008 older 2021
Headquarters
Grenoble, France Geneva, Switzerland
Employees
34 larger 6
Industry
Biotechnology, Health Care Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Series C Unknown
Total Funding
$15.70M $2.28M
Funding Rounds
3 5
Services
High Content Screening, Assay Development, Cellular Models, Physiological Assays Predict systemic drug response, Human multi-tissue drug profiling, In vitro human physiological evaluations, Post-Assay Tissue Sorting, Drug MoA (Mechanism of Action) Analysis, Development of multiplexed selectivity assays
Target Customers
Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Academic Institutions Pharmaceutical companies, Biotech firms, Drug discovery researchers, Clinical research organizations
Taxonomy
Not tracked yet In Vitro Drug Discovery, High-throughput Solutions, 3D Cell Systems, Drug Delivery Study, Target Selectivity Multiplexing, Systemic Efficacy Assessment, Toxicity Measurement, Biomarker Identification, Translational Species Optimization, Human Response Simulation, Adverse Side Effect Reduction, Animal Experimentation Reduction, Systemic Drug Discovery, Human Physiological Responses, Hazardous Chemical Protection
Website
cytoo.com fluosphera.com
CYTOO logo

About CYTOO

CYTOO is a preclinical stage drug discovery company specializing in muscular and neuromuscular disorders. The company partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies while also developing its own drug candidates. The core expertise of CYTOO lies in...

FluoSphera logo

About FluoSphera

FluoSphera, founded in 2021 and headquartered in Switzerland, stands out as a pioneer in the biotechnology and life sciences industry. With its slogan, "The only company with a suite of systemic and high-throughput in vitro drug discovery solutions," the firm emphasizes its unique value proposition....

We will tell you when either one moves

BounceWatch watches CYTOO and FluoSphera for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CYTOO and FluoSphera — by email.

Frequently Asked Questions

CYTOO. FluoSphera — The only company with a suite of systemic and high-throughput in vitro drug discovery solutions. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CYTOO has raised $15.70M while FluoSphera has raised $2.28M.
CYTOO and FluoSphera operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CYTOO with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CYTOO on 11 Jun 2025, and FluoSphera on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy